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A 34-year-old primigravida woman was referred to 
the hospital at 31 gestational weeks because of limb
deformities in the fetus. The woman and her husband
were healthy, and there was no family history of skele-
tal abnormalities. Two-dimensional (2D) ultrasound
examination revealed polyhydramnios, frontal bossing,
a depressed nasal bridge, a narrow chest, a protuberant
abdomen, macrocephaly, shortening of the long bones,
and bowing in the femurs (Figure 1). The amniotic
fluid index was 300 mm. The femur length measured
2.52 cm (normal, 5.39–6.39 cm), tibia length 1.72 cm
(normal, 4.82–5.98 cm), fibula length 1.89 cm (nor-
mal, 4.68–6.18 cm), humerus length 2.08 cm (normal,
4.85–6.01 cm), ulna length 2.11 cm (normal, 4.58–
5.94 cm) and radius length 1.98 cm (normal, 3.97–
5.33 cm). The long-bone measurements were below
the 5th percentile of the normal biometry. The thoracic
circumference (TC) was 18.79cm (normal, 20–25.5cm).
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Figure 1. Two-dimensional ultrasound at 31 gestational weeks
shows (A) polyhydramnios, facial dysmorphism, and a narrow
chest; (B) macrocephaly, frontal bossing, and a depressed nasal
bridge; and (C) a telephone receiver-like short curved femur.
The abdominal circumference (AC) was 28.85 cm
(normal, 22.89–28.66 cm). The TC/AC ratio was 0.73.
The biparietal diameter (BPD) was 9.08 cm (normal,
7.66–8.56 cm), and the head circumference (HC) was
31.73 cm (normal, 27.63–32.16 cm). The HC/AC ratio
was 1.23 (normal, 0.96–1.17). Three-dimensional (3D)
ultrasound showed frontal bossing, a depressed nasal
bridge, short limbs, and increased subcutaneous tis-
sues in the digits and limbs (Figure 2). The 2D and 3D
sonographic findings were consistent with the diagnosis
of thanatophoric dysplasia type I (TD1). The female
baby was delivered with a body weight of 1,696 g and a
body length of 32.5 cm and with neonatal death. X-ray
showed platyspondyly, metaphyseal flaring, a narrow
chest, short curved femurs, and short long bones of the
other limbs (Figure 3). Cytogenetic analysis revealed 
a karyotype of 46,XX. Molecular analysis revealed a
heterozygous 742CT (R248C) mutation caused by a
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Figure 2. Three-dimensional ultrasound at 31 gestational weeks shows (A),
(B), (C) and (D) frontal bossing, a depressed nasal bridge and increased
subcutaneous tissues in the limbs and digits, (E) and (F) shortening of the
upper limbs, and (G) shortening of the lower limbs.
CT transition at nucleotide 742 in exon 7 of the
fibroblast growth factor receptor-3 gene (FGFR3)
leading to an Arg248Cys (CGCTGC) substitution.
Thanatophoric dysplasia (TD) is one of the most
common neonatal lethal skeletal dysplasias with an
estimated prevalence rate of 0.2–0.5/10,000 births
[1]. TD is subdivided into two types; TD1 is character-
ized by short limbs, a narrow thoracic cage, and curved
femurs with or without a cloverleaf skull, whereas TD2
is characterized by short limbs, a narrow thoracic cage,
straight femurs, and a cloverleaf skull [2]. Both TD1
and TD2 are caused by mutations in the FGFR3
gene [3–9]. TD1 is caused by as many as 12 distinct
missense FGFR3 mutations, such as R248C, S249C,
G370C, S371C, Y373C, K650M, J807G, J807R, J807L,
J807C(2421AT), J807C(2421AC) and J807W [2].
The missense mutation 742CT causing an arginine
to cysteine substitution (R248C) occurs most often 
in cases with TD1 [2]. TD2 is caused by a missense
mutation of K650E in the FGFR3 gene [2].
As shown in the present case, macrocephaly, polyhy-
dramnios, craniofacial dysmorphism, chest narrowing,
and femoral bowing are apparent on 2D ultrasound.
3D ultrasound additionally enhances the visualization
of fetal structural abnormalities. We suggest that 3D
ultrasound is a useful adjunct to 2D ultrasound in the
third-trimester prenatal diagnosis and parental coun-
seling of TD1.
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Figure 3. X-ray shows platyspondyly, metaphyseal flaring, 
a narrow chest, short curved femurs, and short long bones 
of the other limbs.
